Using T Using T e c hnology to Impr e c hnology to Impr ove ove - PDF document

6/10/2019 Using T Using T e c hnology to Impr e c hnology to Impr ove ove Me dic ation Adhe r Me dic ation Adhe r e nc e e nc e L L a c e y Bla nke nship, Pha rm.D., BCPS, NCPS a c e y Bla nke nship, Pha rm.D., BCPS, NCPS Chie f Pha rma c ist, Musc o g e e (Cre e k) Na tio n, Oke ma h I Chie f Pha rma c ist, Musc o g e e (Cre e k) Na tio n, Oke ma h I ndia n He a lth Clinic ndia n He a lth Clinic F F inanc ial Disc losure s inanc ial Disc losure s Unde r g uide line s e sta b lishe d b y the Ac c re dita tio n Unde r g uide line s e sta b lishe d b y the Ac c re dita tio n Co unc il fo r Pha rma c y E Co unc il fo r Pha rma c y E duc a tio n, disc lo sure must b e duc a tio n, disc lo sure must b e ma de re g a rding fina nc ia l re la tio nships with ma de re g a rding fina nc ia l re la tio nships with c o mme rc ia l inte re sts within the la st 12 mo nths. c o mme rc ia l inte re sts within the la st 12 mo nths.  I  I ha ve no re le va nt fina nc ia l re la tio nships o r ha ve no re le va nt fina nc ia l re la tio nships o r a ffilia tio ns with c o mme rc ia l inte re sts to disc lo se . a ffilia tio ns with c o mme rc ia l inte re sts to disc lo se . 1

6/10/2019 L L e ar e ar ning Obje c tive s ning Obje c tive s At the c o mple tio n o f this a c tivity, pha rma c ists a nd At the c o mple tio n o f this a c tivity, pha rma c ists a nd pha rma c y te c hnic ia ns will b e a b le to : pha rma c y te c hnic ia ns will b e a b le to :  De sc rib e the impa c t o f me dic a tio n a dhe re nc e o n  De sc rib e the impa c t o f me dic a tio n a dhe re nc e o n pa tie nt he a lth pa tie nt he a lth  Disc uss a va ila b le to o ls to impro ve me dic a tio n  Disc uss a va ila b le to o ls to impro ve me dic a tio n a dhe re nc e a dhe re nc e  I  I de ntify the pha rma c ist’ s/ te c hnic ia n’ s ro le in de ntify the pha rma c ist’ s/ te c hnic ia n’ s ro le in me dic a tio n a dhe re nc e me dic a tio n a dhe re nc e Among patie nts with c hr Among patie nts with c hr onic illne ss, onic illne ss, appr appr oximate ly _____ do not take me dic ations oximate ly _____ do not take me dic ations as pr as pr e sc r e sc r ibe d. ibe d. a . 25% a . 25% b . 50% b . 50% c . 75% c . 75% d. 95% d. 95% 2

6/10/2019 Whic h of the following tools ar Whic h of the following tools ar e use d to e use d to impr impr ove me dic ation adhe r ove me dic ation adhe r e nc e ? e nc e ? a . Sma rt Pill Bo ttle s a . Sma rt Pill Bo ttle s b . I b . I ng e stib le Pill Se nso rs ng e stib le Pill Se nso rs c . Mo b ile Apps c . Mo b ile Apps d. All o f the a b o ve d. All o f the a b o ve Me dic ation adhe r Me dic ation adhe r e nc e is the e nc e is the re sponsibility of _____________. re sponsibility of _____________. a . the pa tie nt. a . the pa tie nt. b . the pro vide r. b . the pro vide r. c . the pha rma c ist. c . the pha rma c ist. d. a ll o f the a b o ve . d. a ll o f the a b o ve . 3

6/10/2019 “Dr “Dr ugs don’t wor ugs don’t wor k in k in patie nts who don’t patie nts who don’t take the m.” take the m.” F F o rme r Surg e o n Ge ne ra l C. E o rme r Surg e o n Ge ne ra l C. E ve re tt K ve re tt K o o p o o p Me dic ation Adhe r Me dic ation Adhe r e nc e Statistic s e nc e Statistic s  Amo ng pa tie nts with c hro nic illne ss, ~50% do no t  Amo ng pa tie nts with c hro nic illne ss, ~50% do no t ta ke me dic a tio ns a s pre sc rib e d. ta ke me dic a tio ns a s pre sc rib e d.  Po o r a dhe re nc e is e stima te d to inc ur c o sts o f $100-  Po o r a dhe re nc e is e stima te d to inc ur c o sts o f $100- $300 b illio n/ ye a r. $300 b illio n/ ye a r.  No na dhe re nc e c a use s 125,000 de a ths a nnua lly  No na dhe re nc e c a use s 125,000 de a ths a nnua lly 4

6/10/2019 Why is adhe r Why is adhe r e nc e a pr e nc e a pr oble m? oble m?  Uninte ntio na l  Uninte ntio na l Why is adhe r Why is adhe r e nc e a pr e nc e a pr oble m? oble m?  Side e ffe c ts  Side e ffe c ts 5

6/10/2019 Why is adhe r Why is adhe r e nc e a pr e nc e a pr oble m? oble m?  Misunde rsta nding  Misunde rsta nding Me dic ation Adhe r Me dic ation Adhe r e nc e T e nc e T ools ools  I  I ng e stib le Pill Se nso rs ng e stib le Pill Se nso rs  Sma rt Pill Bo ttle s  Sma rt Pill Bo ttle s  Adhe re nc e Pa c ka g ing  Adhe re nc e Pa c ka g ing  No t ide a l fo r ra pidly c ha ng ing dise a se sta te s  No t ide a l fo r ra pidly c ha ng ing dise a se sta te s  Me dic a tio n Co mplia nc e Pro g ra ms  Me dic a tio n Co mplia nc e Pro g ra ms 6

6/10/2019 Me dic ation Adhe r Me dic ation Adhe r e nc e T e nc e T ools, c ont. ools, c ont.  Mo b ile Apps  Mo b ile Apps  160 re la te d to me dic a tio n a dhe re nc e  160 re la te d to me dic a tio n a dhe re nc e  Me diSa fe – 81% a dhe re nc e ra te a mo ng use rs  Me diSa fe – 81% a dhe re nc e ra te a mo ng use rs  Pro s: c he a p, e a sily a c c e ssib le , inc lude me dic a tio n re fe re nc e s  Pro s: c he a p, e a sily a c c e ssib le , inc lude me dic a tio n re fe re nc e s  Co ns: use r de pe nde nt, indire c t me a sure me nt, se c urity issue s  Co ns: use r de pe nde nt, indire c t me a sure me nt, se c urity issue s Me dic ation Adhe r Me dic ation Adhe r e nc e T e nc e T ools, c ont. ools, c ont.  Mo b ile T  Mo b ile T e xt Me ssa g ing e xt Me ssa g ing  At le a st 80% o f Ame ric a ns o wn so me type o f c e ll pho ne  At le a st 80% o f Ame ric a ns o wn so me type o f c e ll pho ne  Me ta -a na lysis o f 16 RCT  Me ta -a na lysis o f 16 RCT s sho we d a n inc re a se o f 17.8% in a dhe re nc e s sho we d a n inc re a se o f 17.8% in a dhe re nc e ra te s ra te s 7

6/10/2019 T T he Pharmac ist’s Role he Pharmac ist’s Role  4,785 a c tive pha rma c ists re g iste re d in Okla ho ma  4,785 a c tive pha rma c ists re g iste re d in Okla ho ma  Adhe re nc e ra te s o f 80% o r mo re a re ne e de d fo r  Adhe re nc e ra te s o f 80% o r mo re a re ne e de d fo r o ptima l the ra pe utic e ffic a c y o ptima l the ra pe utic e ffic a c y  Adhe re nc e ra te s inc re a se whe n te c hno lo g y is  Adhe re nc e ra te s inc re a se whe n te c hno lo g y is c o mb ine d with fa c e -to -fa c e inte rve ntio n c o mb ine d with fa c e -to -fa c e inte rve ntio n  Co nside r me dic a tio n no na dhe re nc e first a s the  Co nside r me dic a tio n no na dhe re nc e first a s the re a so n a pa tie nt’ s c o nditio n is no t unde r c o ntro l re a so n a pa tie nt’ s c o nditio n is no t unde r c o ntro l Among patie nts with c hr Among patie nts with c hr onic illne ss, onic illne ss, appr appr oximate ly _____ do not take me dic ations oximate ly _____ do not take me dic ations as pr as pr e sc r e sc r ibe d. ibe d. a . 25% a . 25% b . 50% b . 50% c . 75% c . 75% d. 95% d. 95% 8

6/10/2019 Whic h of the following tools ar Whic h of the following tools ar e use d to e use d to impr impr ove me dic ation adhe r ove me dic ation adhe r e nc e ? e nc e ? a . Sma rt Pill Bo ttle s a . Sma rt Pill Bo ttle s b . I b . I ng e stib le Pill Se nso rs ng e stib le Pill Se nso rs c . Mo b ile Apps c . Mo b ile Apps d. All of the above d. All of the above Me dic ation adhe r Me dic ation adhe r e nc e is the e nc e is the re sponsibility of _____________. re sponsibility of _____________. a . the pa tie nt. a . the pa tie nt. b . the pro vide r. b . the pro vide r. c . the pha rma c ist. c . the pha rma c ist. d. all of the above . d. all of the above . 9